ArticleFrontiers in oncology2023

Pan-cancer analysis identifies LIFR as a prognostic and immunological biomarker for uterine corpus endometrial carcinoma.

Fang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.